SFERRAZZA, Carmela
 Distribuzione geografica
Continente #
NA - Nord America 1.174
EU - Europa 884
AS - Asia 263
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
SA - Sud America 1
Totale 2.328
Nazione #
US - Stati Uniti d'America 1.173
FI - Finlandia 233
CN - Cina 197
UA - Ucraina 194
IT - Italia 176
DE - Germania 64
IE - Irlanda 59
GB - Regno Unito 53
SE - Svezia 32
RU - Federazione Russa 22
SG - Singapore 20
BE - Belgio 18
KR - Corea 16
FR - Francia 10
IR - Iran 9
RO - Romania 9
IN - India 7
TR - Turchia 6
EU - Europa 5
NL - Olanda 4
VN - Vietnam 4
CH - Svizzera 3
PL - Polonia 3
BG - Bulgaria 2
HK - Hong Kong 2
CA - Canada 1
CZ - Repubblica Ceca 1
ES - Italia 1
IQ - Iraq 1
JP - Giappone 1
NZ - Nuova Zelanda 1
VE - Venezuela 1
Totale 2.328
Città #
Chandler 141
Ann Arbor 109
Jacksonville 109
Ashburn 92
Fairfield 67
Dublin 59
Wilmington 57
Woodbridge 56
Houston 55
Medford 44
Dearborn 34
Palermo 33
Nanjing 32
New York 32
Princeton 28
Tulsa 25
Seattle 23
Altamura 22
Cambridge 22
Boardman 20
Brussels 18
Jinan 17
Shenyang 17
Beijing 16
Hebei 15
Nanchang 15
Seongnam 14
Lawrence 13
Tianjin 13
Changsha 12
Milan 11
Bremen 10
Ludwigshafen am Rhein 10
Singapore 10
San Diego 9
San Mateo 8
Düsseldorf 7
Helsinki 7
Jiaxing 7
Des Moines 6
Izmir 6
Kunming 6
Lanzhou 6
Verona 6
Zhengzhou 6
Auburn Hills 5
Guangzhou 5
Kumar 5
Macomb 5
Taizhou 5
Hanoi 4
Kitzingen 4
Saint Petersburg 4
Tehran 4
Andover 3
Hangzhou 3
Las Vegas 3
Los Angeles 3
Ningbo 3
Reggio Emilia 3
Sacramento 3
San Paolo di Civitate 3
Shanghai 3
Stockholm 3
Taiyuan 3
Venice 3
Central District 2
Florence 2
Fuzhou 2
Haikou 2
Hefei 2
Indiana 2
Islington 2
Moscow 2
Mountain View 2
Norwalk 2
Paris 2
Phoenix 2
Washington 2
Alcamo 1
Amsterdam 1
Auckland 1
Augusta 1
Capaci 1
Delft 1
Den Haag 1
Distrito Federal 1
Durham 1
Edinburgh 1
Frankfurt Am Main 1
Frankfurt am Main 1
Guiyang 1
Gunzenhausen 1
Kashan 1
Kilburn 1
Leawood 1
Ludwigshafen 1
Madrid 1
Olomouc 1
Ottawa 1
Totale 1.449
Nome #
FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa 156
Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. 140
Cognitive Impairment and Osteoporosis in persons 50+ years old: a population-based study. 124
Oral pathology in untreated coeliac disease 111
Alendronate 70 mg on patients affected with thalassemia major: An observational study 107
Il polimorfismo C4887A del gene CYP1A1 influenza il metabolismo estrogenico e la massa ossea 104
MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. 100
The malnutrition in the elderly: a clinical approach. 99
Persistence of the deficit of bone mineral density ( BMD ) in adult subjects with celiac disease in dietary treatment 94
-Correlation between deficiency of 25 (OH) vitamin D and liver damage in adult talassemic subjects 89
Bone turnover markers in postmenopausal womens treated with alendronate or risedronate: differences in early dynamics 86
Asymptomatic infection, blood donors and risk of trasmission of Leishmania. A multicentric study 81
ACTIVIN A CIRCULATING LEVELS IN PATIENTS WITH PRIMARY OSTEOPOROSIS OR BONE METASTASES FROM BREAST CANCER 81
In vitro effects of aminobisphosphonates on Vgamma9Vdelta2 T cell activation and differentiation. 80
Activin A circulating levels in Patients with primary osteoporosis or bone metastases from brest cancer 78
Correlation between deficiency of 25 (OH)-vitamin D, bone mineral density and markers of bone turnover in sicilian postmenopausal womens 75
La Familiarità per l'osteoporosi come fattore predittivo per il metabolismo estrogenico 74
Two novel mutations at exon 8 of Sequestosome 1 gene (SQSTM 1)in an Italian series of patient affected by Paget’s disease of bone (PDB) 72
Osteoporotic risk in Crohn's disease. 71
Correlation between deficiency of 25 (OH) vitamin D, bone mineral density and markers of bone turnover in sicialian postmenopausal womens 71
Activin A circulating levels in patients with osteoporosis or bone metastasis from breast cancer 71
Il trattamento dell'iperparatiroidismo primitivo asintomatico:una controversia ancora aperta 70
Differences in early dynamics of serum bone markers in women with postmenopausal osteoporosiseated by alendronate or risedronate 66
Prevalence and identification of vertebral fractures: Comparison of visual inspection, digital computerized morphometry and visual semiquantitative assessment 65
Differences in early dynamics of serum bone markers in women with postmenopausal osteoporosis treated by alendronate or risedronate 61
Portatori asintomatici di Leishmania, trasfusioni e rischio di trasmissione interumana.Una ricerca sul campo 59
Clinical significance of Activin A serum levels in patients with primary osteoporosis: a preliminary report 51
null 47
LIVELLI CIRCOLANTI DI ACTIVINA A IN PAZIENTI CON OSTEOPOROSI PRIMITIVA O METASTASI OSSEE DA CARCINOMA MAMMARIO 12
Totale 2.395
Categoria #
all - tutte 7.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020464 69 5 30 16 51 59 58 10 46 18 73 29
2020/2021276 8 33 2 34 27 7 29 7 50 10 34 35
2021/2022283 2 79 3 9 8 5 7 8 46 44 11 61
2022/2023394 53 63 7 52 47 55 8 31 54 1 20 3
2023/2024194 7 33 14 25 9 58 13 4 2 1 1 27
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 2.395